Outcome
By: Albert D. Min, MD
|
Join Albert D. Min, MD, as he discusses the treatment and management of chronic hepatitis B virus infection
Date Posted: 9/5/2008
|
 |
Download a HBV core curriculum slideset on the treatment and management of HBV for self study or use in your own presentations.
File Format: Microsoft PowerPoint (.ppt) | File Size: 1,358 KB
Date Posted: 9/5/2008
|
By: Ira M. Jacobson, MD
|
Join Ira M. Jacobson, MD, as he reviews the latest data on which HBV therapy to choose, when to change, and when to stop.
Date Posted: 6/25/2008
|
By: Robert G. Gish, MD, Josep M. Llovet, MD, Paul Martin, MD
|
Join Robert G. Gish, MD; Josep M. Llovet, MD; and Paul Martin, MD, as they discuss the most recent data on special hepatic issues and populations presented at the 43rd Annual Meeting of the European Association for the Study of the Liver.
Date Posted: 6/23/2008
|
 |
Download and review key data selected by Daniel Shouval, MD on clinical HBV data that was presented at the 2008 EASL meeting in Milan. Use the slides in your own presentations!
File Format: Microsoft PowerPoint (.ppt) | File Size: 948 KB
Date Posted: 5/9/2008
|
|
Randomized trial suggests a significant reduction in HBsAg level during peginterferon-based therapy is the best predictor of HBsAg clearance during 3 years of follow-up
Date Posted: 4/30/2008
|
|
In this double-blind, randomized trial, 2 tenofovir-containing regimens were shown to significantly decrease HBV DNA at 48 weeks in patients who were previously unresponsive to adefovir therapy
Date Posted: 4/28/2008
|
By: Emmet B. Keeffe, MD, MACP, Fred Poordad, MD, Paul Martin, MD
|
Emmet B. Keeffe, MD, MACP; Fred Poordad, MD; and Paul Martin, MD, discuss important clinical data presented on patients with chronic hepatitis B virus infection at the 2007 liver disease meeting in Boston.
Date Posted: 1/9/2008
|
By: Mitchell L. Shiffman, MD
|
Mitchell L. Shiffman, MD, reviews the various types of virologic response in patients treated for hepatitis C virus infection, discusses what factors are associated with better responses, and summarizes the most recent data available on various retreatment strategies.
Date Posted: 12/5/2007
|
|
10-year retrospective analysis suggests nucleoside analogue treatment not recommended for patients with HBV-related acute liver failure.
Date Posted: 11/9/2007
|
|
Featured Content
2008 Independent Conference Report on Hepatitis B and C Virus Resistance to Antiviral Therapies.
Expert faculty members review the most important advances in hepatitis and its mgmt in 2008.
Review a module and Interactive Case Challenge and use the new HBV DNA monitoring tool.
|